Los Angeles Capital Management LLC Raises Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Los Angeles Capital Management LLC lifted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 482.3% during the 4th quarter, Holdings Channel.com reports. The fund owned 10,330 shares of the biotechnology company’s stock after buying an additional 8,556 shares during the period. Los Angeles Capital Management LLC’s holdings in Axon Enterprise were worth $6,139,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Groupama Asset Managment acquired a new position in Axon Enterprise during the third quarter worth $200,000. Massachusetts Financial Services Co. MA purchased a new position in shares of Axon Enterprise in the third quarter valued at $120,553,000. Westfield Capital Management Co. LP raised its stake in shares of Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after buying an additional 127,769 shares during the last quarter. Assenagon Asset Management S.A. grew its stake in Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after acquiring an additional 111,405 shares during the last quarter. Finally, Champlain Investment Partners LLC increased its holdings in Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after acquiring an additional 83,265 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Robert W. Baird upped their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Northland Securities increased their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. Finally, The Goldman Sachs Group lifted their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $561.31.

Axon Enterprise Stock Up 15.3 %

Shares of NASDAQ AXON opened at $572.40 on Thursday. The firm has a market cap of $43.65 billion, a price-to-earnings ratio of 147.91, a PEG ratio of 5.17 and a beta of 1.05. Axon Enterprise, Inc. has a 1 year low of $265.32 and a 1 year high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock’s 50-day simple moving average is $613.42 and its 200-day simple moving average is $522.06.

Insiders Place Their Bets

In other news, insider Jeffrey C. Kunins sold 2,304 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the sale, the insider now owns 128,542 shares of the company’s stock, valued at approximately $84,168,016.18. This trade represents a 1.76 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now directly owns 2,392 shares of the company’s stock, valued at $1,631,487.52. The trade was a 34.52 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 8,711 shares of company stock worth $5,631,561 in the last three months. 5.70% of the stock is owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.